Jump to Main Content


ASH, the world's largest professional society concerned with the causes and treatments of blood disorders, regularly issues press releases highlighting clinical and research advances announced at the ASH annual meeting and published in Blood, as well as releases and statements on breaking policy news affecting the field of hematology.

News and Press Releases

American Society of Hematology Announces 2023 Scholar Award Recipients
Feb. 2, 2023

ASH Statement New Blood Donor Eligibility Guidelines
Jan. 27, 2023

Robert A. Brodsky, MD, Begins Term as 2023 ASH President
Jan. 10, 2023

Blinatumomab further improves survival among B-lineage ALL patients with a good prognosis
Dec. 13, 2022

Iptacopan Resolves Anemia in Phase III Trial for Paroxysmal Nocturnal Hemoglobinuria
Dec. 13, 2022

Blood Thinners During Pregnancy Made No Difference to Live Birth Rate in Women with Recurrent Miscarriage and Inherited Thrombophilia
Dec. 13, 2022

Next-Generation Targeted Therapy Zanubrutinib Found Superior to Ibrutinib for CLL and SLL
Dec. 13, 2022

Studies Focus on Optimizing Pediatric Care from Birth to Adulthood
Dec. 12, 2022

Research Highlights Cutting-Edge New Treatments for Blood Disorders
Dec. 10, 2022

New Studies Challenge the Dogma of Blood Cancer Care
Dec. 10, 2022

Research Exposes Inequities in Health Care Access and Delivery for Blood Disorders
Dec. 10, 2022

ASH to Recognize Choosing Wisely Champions and Guideline Implementation Champions
Dec. 9, 2022

ASH Announces Recipients of 2022 Advocacy Awards
Dec. 7, 2022

View All

Protect Medical Research

Urge your members of Congress to support continued medical research funding.

Take Action